169280-61-9

Basic information

• Product Name: Carbamic acid, [(1S,2R)-3-[[(2-amino-6-benzothiazolyl)sulfonyl](2-methylpropyl)amino]- 2-hydroxy-1-(phenylmethyl)propyl]-, phenylmethyl ester
• CAS NO: 169280-61-9
• Molecular Formula: C29H34N4O5S2
• Molecular Weight: 582.745
• Mol File: 169280-61-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S,2R)-3-[[(2-amino-6-benzothiazolyl)sulfonyl](2-methylpropyl)amino]- 2-hydroxy-1-(phenylmethyl)propyl]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S,2R)-3-[[(2-amino-6-benzothiazolyl)sulfonyl](2-methylpropyl)amino]- 2-hydroxy-1-(phenylmethyl)propyl]-, phenylmethyl ester(169280-61-9)
• EPA Substance Registry System: Carbamic acid, [(1S,2R)-3-[[(2-amino-6-benzothiazolyl)sulfonyl](2-methylpropyl)amino]- 2-hydroxy-1-(phenylmethyl)propyl]-, phenylmethyl ester(169280-61-9)

Safety Data

• Hazardous Substances Data: 169280-61-9(Hazardous Substances Data)

Upstream product

• 333-20-0 potassium thioacyanate 
• 143224-62-8 (2R,3S)-3-benzyloxycarbonylamino-2-hydroxy-1-(N-isobutylamino)-4-phenylbutane 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 183554-21-4 3-S-amino-2R-hydroxy-1-[(2-aminobenzothiazol-6-sulfonyl)(2-methylpropyl)amino]-4-phenylbutane 
• 183004-94-6 3-S-(N-tert-butyloxyformamido)-[2R-hydroxy-1-[(4-aminophenylsulfonyl)(2-methylpropyl)]amino]-4-phenylbutane 
• 159005-59-1 4-nitro-N-((2R(syn),3S)-3-(N-benzyloxycarbonylamino)-2-hydroxy-4-phenylbutyl)-N-isobutyl-benzenesulfonamide 
• 169280-56-2 4-amino-N-(2R,3S)(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide 
• 98-74-8 4-Nitrobenzenesulfonyl chloride 

Relevant articles and documents

BROADSPECTRUM 2-AMINO-BENZOTHIAZOLE SULFONAMIDE HIV PROTEASE INHIBITORS

The present invention relates to the use of 2-amino-benzothiazoles, having the formula (I) wherein R1 is hexahydrofuro[2,3-b]furanyl, tetrahydrofuranyl, oxazolyl, thiazolyl, pyridinyl, or phenyl optionally substituted with one or more substitue

Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

Selected bis-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.